Assess whether working capital should be a walk-away (bb4a83)

SITUATION After a Phase II that found groundwater impact, QoE add-backs the seller marked 'normalized' is what commercial-diligence partner can touch in a cross-border deal with earnout-heavy structure. M&A Due Diligence will live with Proceed versus Reprice on this Legal, IP, and Regulatory file.

DECISION Commercial-diligence partner in a cross-border deal with earnout-heavy structure must choose Proceed / Reprice / Walk / Hold using QoE add-backs the seller marked 'normalized' after a Phase II that found groundwater impact.

HYPOTHESES TO TEST 1. QoE add-backs the seller marked 'normalized' reads as Proceed once a Phase II that found groundwater impact is lined up to the same M&A Due Diligence population. 2. QoE add-backs the seller marked 'normalized' is closer to Reprice after a Phase II that found groundwater impact; Proceed would over-claim this Legal, IP, and Regulatory extract. 3. Walk is still live in QoE add-backs the seller marked 'normalized' for commercial-diligence partner in a cross-border deal with earnout-heavy structure. 4. QoE add-backs the seller marked 'normalized' is missing the fact commercial-diligence partner needs after a Phase II that found groundwater impact; stop this M&A Due Diligence close.

ANALYSIS REQUIRED 1. Test whether a Phase II that found groundwater impact is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in QoE add-backs the seller marked 'normalized'. 3. Map reps, earnout mechanics, and integration risk a cross-border deal with earnout-heavy structure would inherit. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read QoE add-backs the seller marked 'normalized' against a Phase II that found groundwater impact and write the one fact that would move working capital should be for commercial-diligence partner.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (QoE add-backs the seller marked 'normalized' after a Phase II that found groundwater impact). Lead with the M&A Due Diligence option QoE add-backs the seller marked 'normalized' can support after a Phase II that found groundwater impact, then the two facts that force it, then the Monday action for commercial-diligence partner in a cross-border deal with earnout-heavy structure.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on working capital should be, then the evidence in QoE add-backs the seller marked 'normalized', then the action for commercial-diligence partner - Hypothesis scorecard against QoE add-backs the seller marked 'normalized': supported / rejected / untestable - Missing page in QoE add-backs the seller marked 'normalized' after a Phase II that found groundwater impact, if any - Regulatory or exam hook Legal, IP, and Regulatory would cite